Ameriprise’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,371
Closed -$433K 4009
2023
Q4
$433K Sell
7,371
-6
-0.1% -$353 ﹤0.01% 3505
2023
Q3
$321K Buy
+7,377
New +$321K ﹤0.01% 3568
2023
Q1
Sell
-637,130
Closed -$28.9M 4051
2022
Q4
$28.9M Sell
637,130
-832,704
-57% -$37.7M 0.01% 1007
2022
Q3
$103M Buy
1,469,834
+7,848
+0.5% +$548K 0.04% 451
2022
Q2
$98.2M Sell
1,461,986
-16,467
-1% -$1.11M 0.03% 485
2022
Q1
$122M Buy
1,478,453
+5,847
+0.4% +$481K 0.04% 459
2021
Q4
$216M Sell
1,472,606
-112,393
-7% -$16.5M 0.06% 333
2021
Q3
$280M Buy
1,584,999
+1,167,647
+280% +$207M 0.09% 238
2021
Q2
$67.4M Buy
417,352
+114,710
+38% +$18.5M 0.02% 663
2021
Q1
$51.8M Sell
302,642
-2,634
-0.9% -$451K 0.02% 756
2020
Q4
$67.1M Sell
305,276
-148,161
-33% -$32.5M 0.02% 611
2020
Q3
$75.3M Sell
453,437
-45,670
-9% -$7.58M 0.03% 504
2020
Q2
$57M Buy
499,107
+326,275
+189% +$37.2M 0.02% 571
2020
Q1
$13.3M Buy
172,832
+82,208
+91% +$6.32M 0.01% 1195
2019
Q4
$11.7M Sell
90,624
-32,820
-27% -$4.23M ﹤0.01% 1614
2019
Q3
$9.61M Sell
123,444
-24,123
-16% -$1.88M ﹤0.01% 1717
2019
Q2
$15.2M Sell
147,567
-5,370
-4% -$553K 0.01% 1380
2019
Q1
$11.2M Sell
152,937
-52,345
-25% -$3.84M 0.01% 1608
2018
Q4
$8.7M Buy
205,282
+66,953
+48% +$2.84M ﹤0.01% 1715
2018
Q3
$6.54M Buy
138,329
+110,296
+393% +$5.22M ﹤0.01% 2171
2018
Q2
$1.38M Buy
28,033
+16,930
+152% +$835K ﹤0.01% 2886
2018
Q1
$341K Sell
11,103
-7,575
-41% -$233K ﹤0.01% 3320
2017
Q4
$341K Buy
+18,678
New +$341K ﹤0.01% 3321